HK1254314A1 - 成骨移植物形成单元 - Google Patents

成骨移植物形成单元 Download PDF

Info

Publication number
HK1254314A1
HK1254314A1 HK18113282.0A HK18113282A HK1254314A1 HK 1254314 A1 HK1254314 A1 HK 1254314A1 HK 18113282 A HK18113282 A HK 18113282A HK 1254314 A1 HK1254314 A1 HK 1254314A1
Authority
HK
Hong Kong
Prior art keywords
forming unit
graft forming
osteogenic graft
disclosed
methods
Prior art date
Application number
HK18113282.0A
Other languages
English (en)
Chinese (zh)
Inventor
Francois Binette
Brent Atkinson
David Larocca
Original Assignee
Orthocyte Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orthocyte Corporation filed Critical Orthocyte Corporation
Publication of HK1254314A1 publication Critical patent/HK1254314A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0654—Osteocytes, Osteoblasts, Odontocytes; Bones, Teeth
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0655—Chondrocytes; Cartilage
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/155—Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins
    • C12N2533/54—Collagen; Gelatin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/70—Polysaccharides
    • C12N2533/80—Hyaluronan

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HK18113282.0A 2015-06-09 2016-06-09 成骨移植物形成单元 HK1254314A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562172808P 2015-06-09 2015-06-09
US62/172,808 2015-06-09
PCT/US2016/036778 WO2016201154A1 (en) 2015-06-09 2016-06-09 Osteogenic graft forming unit

Publications (1)

Publication Number Publication Date
HK1254314A1 true HK1254314A1 (zh) 2019-07-19

Family

ID=57504258

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18113282.0A HK1254314A1 (zh) 2015-06-09 2016-06-09 成骨移植物形成单元

Country Status (7)

Country Link
US (1) US20180325958A1 (enExample)
EP (1) EP3307287A4 (enExample)
JP (1) JP6875297B2 (enExample)
AU (1) AU2016274785A1 (enExample)
CA (1) CA2988778A1 (enExample)
HK (1) HK1254314A1 (enExample)
WO (1) WO2016201154A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013010045A1 (en) 2011-07-12 2013-01-17 Biotime Inc. Novel methods and formulations for orthopedic cell therapy
WO2018115871A1 (en) * 2016-12-20 2018-06-28 The University Of Birmingham Composition and method for bone production
JP7204730B2 (ja) * 2017-03-31 2023-01-16 セラム バイオメディカル， インコーポレイテッド 生体適合性馴化細胞培地組成物およびその使用
CN108452378B (zh) * 2018-02-08 2020-10-23 中山大学附属第一医院 一种3d生物打印成型方法
CN108310463B (zh) * 2018-02-08 2020-10-23 中山大学附属第一医院 一种3d打印生物墨水及其制备方法
KR102232283B1 (ko) * 2018-07-26 2021-03-25 에이비온 주식회사 연골세포 분화 마커
CN109568665B (zh) * 2018-12-28 2021-12-10 中国医科大学附属第一医院 负载脂肪干细胞外泌体的温敏型可注射水凝胶及其制备方法和应用
EP3960848A4 (en) * 2019-04-23 2023-07-26 Cellatoz Therapeutics, Inc. METHOD FOR REGULATING SELECTIVE DIFFERENTIATION OF MUSCULOSKELETAL STEM CELLS
KR102236635B1 (ko) * 2019-09-04 2021-04-13 경북대학교 산학협력단 Meox2 억제제를 유효성분으로 포함하는 발치와 골 재생 촉진용 조성물
KR102104933B1 (ko) * 2019-10-31 2020-04-27 주식회사 라이프온 줄기세포 유래 엑소좀을 함유하는 치아 재강화 또는 치아골 이식재 조성물 및 그 제조방법
CN110684710A (zh) * 2019-11-23 2020-01-14 吉林省蔚来生物科技有限公司 一种骨膜生物支架与异体种子细胞复合的培养方法
JP2021159499A (ja) * 2020-04-01 2021-10-11 株式会社Dr.Cherry 骨形成を促進することに用いられる新生骨の支持体
KR102463245B1 (ko) * 2020-06-19 2022-11-07 동국대학교 산학협력단 Mettl7a 과발현 줄기세포를 포함하는 골재생용 조성물, 이를 제조하는 방법 및 이를 포함하는 세포치료제
CN113249332A (zh) * 2021-07-15 2021-08-13 北京大学第三医院（北京大学第三临床医学院） 一种alpl基因缺失骨髓间充质干细胞的建立方法
EP4230232A1 (en) 2022-02-16 2023-08-23 Hacettepe Üniversitesi Binding of calcium phosphate bioceramic and exosomes via annexin v mediator molecule
CN115957378B (zh) * 2023-02-08 2024-10-22 上海交通大学医学院附属瑞金医院 一种骨修复组合物及其制备方法和应用
CN118028212B (zh) * 2024-04-12 2024-06-18 广东医科大学附属医院 土元外泌体在制备抗骨质疏松药物中的应用、药物
CN120209114A (zh) * 2025-03-07 2025-06-27 首都医科大学 一种含有penk蛋白的组合物及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1722765A2 (en) * 2004-01-28 2006-11-22 The Regents of The University of Michigan Osteoblast factor(s) that regulates human prostate cancer migration to and invasion of bone
CH700138B1 (it) * 2008-12-19 2012-12-14 Ind Biomediche Insubri S A Matrice per impianto osseo e procedimento di preparazione della stessa.
WO2013010045A1 (en) * 2011-07-12 2013-01-17 Biotime Inc. Novel methods and formulations for orthopedic cell therapy
JP2015523058A (ja) * 2012-05-10 2015-08-13 バイオマトセル アクチエボラグＢｉｏｍａｔｃｅｌｌ ＡＢ 間葉系幹細胞の骨形成分化
US20140178988A1 (en) * 2012-10-08 2014-06-26 Biotime, Inc. Differentiated Progeny of Clonal Progenitor Cell Lines
AU2014284440B2 (en) * 2013-07-01 2018-07-19 Amit Prakash Govil Soft tissue implant
JP2016529057A (ja) * 2013-09-02 2016-09-23 マフィン・インコーポレイテッドＭｕｆｆｉｎ Ｉｎｃｏｒｐｏｒａｔｅｄ 細胞外マトリックス組織物質および骨原性タンパク質を含む生成物

Also Published As

Publication number Publication date
JP6875297B2 (ja) 2021-05-19
CA2988778A1 (en) 2016-12-15
AU2016274785A1 (en) 2017-12-07
EP3307287A4 (en) 2018-12-19
US20180325958A1 (en) 2018-11-15
EP3307287A1 (en) 2018-04-18
JP2018520750A (ja) 2018-08-02
WO2016201154A1 (en) 2016-12-15

Similar Documents

Publication Publication Date Title
HK1254314A1 (zh) 成骨移植物形成单元
ZA201903308B (en) Conjugated biological molecules, pharmaceutical compositions and methods
CA2883095C (en) Antibody and protein formulations
EP3665181A4 (en) COMPOSITIONS AND PROCEDURES FOR DECOLONIZATION OF ANTIBIOTIC-RESISTANT BACTERIA IN THE INTESTINAL
SG10201803042PA (en) Anti-tim-3 antibodies
EP3368086A4 (en) SKIN ADHESIVES, ANTIMICROBIAL COMPOSITIONS, ARTICLES AND METHODS OF USE THEREOF
WO2018109170A3 (en) Il-11ra antibodies
WO2016061286A3 (en) Compositions of adenosine deaminase-2 (ada2), variants thereof and methods of using same
CA2956871C (en) Compounds active towards bromodomains
HK1258758A1 (zh) 分支的寡核苷酸
EP3491026A4 (en) HUMAN ANTIBODIES, PHARMACEUTICAL COMPOSITIONS AND METHODS
EP3315608A4 (en) Sirna, pharmaceutical composition and conjugate which contain sirna, and uses thereof
EP4491184A3 (en) Channel modulators
EP3929293A3 (en) Fully stabilized asymmetric sirna
EP3995581A3 (en) Oligonucleotide compounds for treatment of preeclampsia and other angiogenic disorders
WO2015112886A3 (en) Binding proteins and methods of use thereof
EP4470557A3 (en) Anti-cgrp antibody formulation
WO2015168019A3 (en) Anti-ptk7 antibody-drug conjugates
EP3173074A4 (en) Composition for delivering bioactive material or protein, and use thereof
WO2017106364A3 (en) Compositions and methods for treatment of retinitis pigmentosa 18 and retinitis pigmentosa 13
GB2532302B (en) Antimicrobial preparations, methods for preparing the same and uses thereof to combat microorganisms.
EP3569596A4 (en) 1,2,4-TRIAZINE-3-AMINE DERIVATIVE, PROCESS OF PREPARATION AND USE IN MEDICINE
WO2015058132A3 (en) Anti-rsp02 and/or anti-rsp03 antibodies and their uses
WO2017079570A3 (en) Splise-switching oligonucleotides and methods of use
WO2016128838A3 (en) Lipid compositions